Who Should Deliver Palliative Care in Liver Disease? Chris Woodrell, Manisha Verma, Marie Bakitas
From GeriPal - A Geriatrics and Palliative Medicine Podcast · · 50 min
This plays from the publisher's own server. We do not host a copy.
Description
Who's better at delivering palliative care to patients with liver disease: palliative care specialists, or hepatologists who have received liver disease-specific palliative care training?
That's the question we take a deep dive into on this week's podcast by breaking down the PAL-LIVER trial, published this year in JAMA Internal Medicine. We've invited three of the trial's authors, Manisha Verma, Chris Woodrell, and Marie Bakitas, to discuss this cluster-randomized clinical trial spanning 19 U.S. medical centers.
We'll discuss:
- Why was this trial done?
- Do we really need to run a separate palliative care trial for every single organ disease?
- What kind of specialized palliative care training did the hepatologists receive?
- What exactly is meant by the finding that hepatologists were not statistically superior, but were shown to be statistically non-inferior?
Lastly, we discuss whether these results change anyone's practice, and whether healthcare systems should decide which type of palliative care model to fund (primary vs. specialty.)
—-
References we discussed
- Developing palliative care interventions in liver disease using formative and summative qualitative evaluation. Hepatology 2026
- Palliative Care for Advanced Liver Disease: Hepatology and Palliative Care Specialists Experiences. J Pain Symptom Manage 2026
Back to GeriPal - A Geriatrics and Palliative Medicine Podcast · Report a problem